Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and risk of ARB and ACEi among different ethnic groups in England: A reference trial (ONTARGET) emulation analysis using UK Clinical Practice Research Datalink Aurum-linked data.
Baptiste PJ, Wong AYS, Schultze A, Clase CM, Leyrat C, Williamson E, Powell E, Mann JFE, Cunnington M, Teo K, Bangdiwala SI, Gao P, Wing K, Tomlinson L. Baptiste PJ, et al. Among authors: gao p. PLoS Med. 2024 Sep 16;21(9):e1004465. doi: 10.1371/journal.pmed.1004465. eCollection 2024 Sep. PLoS Med. 2024. PMID: 39283941 Free PMC article.
Cardiorenal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET).
Baptiste PJ, Wong AYS, Schultze A, Clase CM, Leyrat C, Williamson E, Powell E, Mann JFE, Cunnington M, Teo K, Bangdiwala SI, Gao P, Tomlinson L, Wing K. Baptiste PJ, et al. Among authors: gao p. Am J Epidemiol. 2024 Dec 2;193(12):1785-1795. doi: 10.1093/aje/kwae137. Am J Epidemiol. 2024. PMID: 38896054 Free PMC article.
Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.
Clase CM, Gao P, Tobe SW, McQueen MJ, Grosshennig A, Teo KK, Yusuf S, Mann JF; ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in Angiotensin-Converting-Enzyme-Inhibitor Intolerant Subjects with Cardiovascular Disease). Clase CM, et al. Among authors: gao p. Ann Intern Med. 2011 Mar 1;154(5):310-8. doi: 10.7326/0003-4819-154-5-201103010-00005. Ann Intern Med. 2011. PMID: 21357908
Risk Prediction for Early CKD in Type 2 Diabetes.
Dunkler D, Gao P, Lee SF, Heinze G, Clase CM, Tobe S, Teo KK, Gerstein H, Mann JF, Oberbauer R; ONTARGET and ORIGIN Investigators. Dunkler D, et al. Among authors: gao p. Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1371-9. doi: 10.2215/CJN.10321014. Epub 2015 Jul 14. Clin J Am Soc Nephrol. 2015. PMID: 26175542 Free PMC article.
Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
Tobe SW, Clase CM, Gao P, McQueen M, Grosshennig A, Wang X, Teo KK, Yusuf S, Mann JF; ONTARGET and TRANSCEND Investigators. Tobe SW, et al. Among authors: gao p. Circulation. 2011 Mar 15;123(10):1098-107. doi: 10.1161/CIRCULATIONAHA.110.964171. Epub 2011 Feb 28. Circulation. 2011. PMID: 21357827 Clinical Trial.
7,225 results